Professional Documents
Culture Documents
Neonates: Clinical Syndromes and Cardinal Fea-Tures of Infectious Diseases: Approach To Diagnosis and Initial Management
Neonates: Clinical Syndromes and Cardinal Fea-Tures of Infectious Diseases: Approach To Diagnosis and Initial Management
Neonates: Clinical Syndromes and Cardinal Fea-Tures of Infectious Diseases: Approach To Diagnosis and Initial Management
From: A Practice of Anesthesia for Infants and Children (Sixth Edition), 2019
Related terms:
Neonates may receive lower morphine infusion rates than older children after
surgery, starting as low as 0.005 mg/kg/h for preterm neonates and 0.01 mg/kg/h for
term neonates. Neonates with cyanotic congenital heart defects also require lower
morphine infusion rates than neonates undergoing noncardiac surgery. Depending
on the dose and other patient characteristics, fentanyl and sufentanil provide vari-
able degrees of suppression of autonomic and hormonal/metabolic responses to
major surgery in neonates, although fentanyl may increase the risk of postoperative
hypothermia. Critically ill neonates, whose vascular tone depends on sympathetic
outflow, may become hypotensive after bolus doses of fentanyl or morphine. In
preterm neonates undergoing ductal closure, higher fentanyl doses (>10.3 mg/kg)
were associated with a decrease in an unstable postoperative respiratory course.
Randomized controlled trials show no differences in the postoperative analgesia
produced by bolus doses versus continuous infusions of morphine; however, ap-
nea or other complications were greater in the bolus-dosing groups. Intravenous
boluses of opioids should be given slowly (over 15 to 30 minutes) to postoperative
neonates.197198199
Pain in Children
Patricia A. McGrath PhD, Stephen C. Brown MD, in Pain Management Secrets (Third
Edition), 2009
Granulocyte Products
Suzanne A. Arinsburg DO, in Transfusion Medicine and Hemostasis (Second Edi-
tion), 2013
Neonatal Sepsis
Neonates are at particular risk for bacterial and fungal infection because of their
diminished storage pool of neutrophils, which can be rapidly depleted; neonates
also have a qualitative defect of neutrophil function. In 1992, Cairo et al. performed
a clinical trial involving 35 neonates with neutropenia and sepsis randomized to
receive either intravenous immunoglobulin (n = 14) or granulocyte transfusion
(n = 21); survival was significantly higher in the granulocyte transfusion group
(100% survival) versus in the immunoglobulin group (64% survival). Studies com-
paring granulocyte transfusion to placebo or no granulocyte transfusion have not
demonstrated a significant difference in all-cause mortality during hospital stay;
though, these studies were small and performed prior to the development and use
of newer antimicrobial medications. Vamvakas et al. performed a meta-analysis of
seven clinical studies in adults and five clinical studies trials in neonates with sepsis
and reported on the efficacy of granulocyte transfusions in the treatment of
bacterial sepsis. These investigators found that the most significant factor in all
of the studies showing favorable outcomes was the dose of granulocytes transfused.
HealthCare–Associated Infections in
the Nursery
Susan E. Coffin, Theoklis E. Zaoutis, in Infectious Diseases of the Fetus and Newborn
(Seventh Edition), 2011
Neonates, especially premature neonates who require intensive medical care, are
among the patients at highest risk for nosocomial or health care–associated infec-
tions (HAIs). Although the rate of HAIs varies with the specific patient population and
institution, some series have reported that more than 20% of critically ill neonates
who survive more than 48 hours acquire a nosocomial infection [1–3]. Neonatal HAIs
are associated with significant morbidity, mortality, and excessive direct health care
costs [3]. Prevention of these infections should be a major priority in all neonatal
intensive care units (NICUs) and nurseries. The most important risk factors for HAIs
in neonates, gestational age and birth weight, cannot be modified. Close attention to
clinical practice and the patient care environment is mandatory to minimize the risk
of infections. This chapter reviews the epidemiology, microbiology, pathogenesis,
and prevention of neonatal HAIs.
TRANSFUSION MEDICINE
Cassandra D. Josephson, Ronald G. Strauss, in Blood Banking and Transfusion
Medicine (Second Edition), 2007
Neutropenia can occur during neonatal bacterial infections, particularly with ful-
minant sepsis. Because a physiologic neutrophilia occurs in normal neonates, it is
considered quite abnormal for the absolute blood PMN count to fall below 3.0 ×
109/L during the first week of life. Although an abnormally low PMN count can occur
in neonates with disorders as diverse as sepsis, asphyxia, and maternal hyperten-
sion, suspicion of severe bacterial infection must always be high whenever relative
neutropenia (PMN count, <3.0 × 109/L) occurs. The mechanisms responsible are
only partially defined, but abnormalities of neonatal granulopoiesis frequently are
involved. As one factor, the postmitotic marrow PMN storage pool (metamyelocytes
and mature, segmented PMNs) is small. The PMN storage pool accounts for 26%
to 60% of all nucleated cells in the bone marrow of normal neonates. Neonates with
sepsis may exhibit a storage pool numbering less than 10% of nucleated marrow
cells and are considered to have severely diminished marrow PMN reserves.75
Second, storage pool PMNs are released at an excessively rapid and, apparently,
poorly regulated rate from the marrow during stress. Third, PMN production in
response to infection is decreased. The number of committed (clonogenic) PMN
precursors in neonatal marrow is lower in neonates than in older patients, and a
high percentage of these cells are proliferating even when studied at an apparently
basal state.75,76 Therefore, neonatal marrow is functioning at capacity and is unable
to rapidly expand production to meet the increased demands of infection.77 For this
reason, it is logical to consider PMN transfusions until the marrow recovers.
Even with validated scales, pain assessment can be limited by a number of factors.
Preterm and term neonates vary in their response and behavior to painful stimuli,
which may often be impaired in the former. There is a paucity of tools for the
assessment of the repetitive painful stimuli in neonates, which vary significantly
from the initial responses to pain. Neonates often become withdrawn exhibiting
a completely different affect when subjected to repeated painful stimuli (Boronat,
Garcia-Fuster, & Garcia-Sevilla, 2001; Grunau, Holsti, & Peters, 2006). Additionally,
these assessment tools fail to assess the subset of population of neonates that are
mechanically ventilated with muscle relaxants and those with neurological problems.
Further refinement of pain assessment tools is a clearly a furtive area for future
research.